A phase II/III randomised, comparative study evaluating the safety and immunogenicity of Biological E's live, attenuated Measles-Rubella vaccine in 9–12 month old healthy infants av Subhash Thuluva, SubbaReddy Gunneri, Kishore Turaga, Rammohan Reddy Mogulla, Vijay Yerroju, Kalyankumar Peta, Pothakamuri Venkata Suneetha, Ramesh V. Matur

Hämta fulltext

Evaluation of safety and immunogenicity of receptor-binding domain-based COVID-19 vaccine (Corbevax) to select the optimum formulation in open-label, multicentre, and randomised ph... av Subhash Thuluva, Vikram Paradkar, Subba Reddy Gunneri, Vijay Yerroju, Rammohan Mogulla, Kishore Turaga, Mahesh Kyasani, Senthil Kumar Manoharan, Guruprasad Medigeshi, Janmejay Singh, Heena Shaman, Chandramani Singh, Venkateshwar Rao A

Hämta fulltext

Immunogenicity and safety of Biological E’s CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a phase-3, single blind, multicentre, randomized clinical... av Subhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, Vijay Yerroju, Rammohan Mogulla, Pothakamuri Venkata Suneetha, Kishore Turaga, Mahesh Kyasani, Senthil Kumar Manoharan, Srikanth Adabala, Aditya Sri Javvadi, Guruprasad Medigeshi, Janmejay Singh, Heena Shaman, Akshay Binayke, Aymaan Zaheer, Amit Awasthi, Chandramani Singh, Venkateshwar Rao A, Indranil Basu, Khobragade Akash Ashok Kumar, Anil Kumar Pandey

Hämta fulltext